Morphologic response to chemotherapy containing bevacizumab in patients with colorectal liver metastases (CLM): A post hoc analysis of the WJOG4407G phase III study

A. Hosokawa, K. Yamazaki, C. Matsuda, S. Ueda, H. Fujii, E. Baba, S. Okamura, M. Tsuda, T. Tamura, K. Shinozaki, T. Tsushima, T. Tsuda, T. Shirakawa, H. Yamashita, S. Morita, K. Muro

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)viii171
JournalAnnals of oncology : official journal of the European Society for Medical Oncology
Volume29
DOIs
Publication statusPublished - Oct 1 2018

All Science Journal Classification (ASJC) codes

  • Hematology
  • Oncology

Cite this

Hosokawa, A., Yamazaki, K., Matsuda, C., Ueda, S., Fujii, H., Baba, E., Okamura, S., Tsuda, M., Tamura, T., Shinozaki, K., Tsushima, T., Tsuda, T., Shirakawa, T., Yamashita, H., Morita, S., & Muro, K. (2018). Morphologic response to chemotherapy containing bevacizumab in patients with colorectal liver metastases (CLM): A post hoc analysis of the WJOG4407G phase III study. Annals of oncology : official journal of the European Society for Medical Oncology, 29, viii171. https://doi.org/10.1093/annonc/mdy281.058